201 related articles for article (PubMed ID: 9588818)
1. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Anning PB; Grocott-Mason RM; Lewis MJ
Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of left ventricular relaxation in the isolated heart by an angiotensin-converting enzyme inhibitor.
Anning PB; Grocott-Mason RM; Lewis MJ; Shah AM
Circulation; 1995 Nov; 92(9):2660-5. PubMed ID: 7586370
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
4. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
6. Free radical scavenging properties of alacepril metabolites and lisinopril.
Noda Y; Mori A; Packer L
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
[TBL] [Abstract][Full Text] [Related]
7. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
9. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
[TBL] [Abstract][Full Text] [Related]
10. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
11. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
[TBL] [Abstract][Full Text] [Related]
12. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart.
Morris SD; Yellon DM
J Am Coll Cardiol; 1997 Jun; 29(7):1599-606. PubMed ID: 9180125
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
Turcani M; Rupp H
Mol Cell Biochem; 2000 Sep; 212(1-2):219-25. PubMed ID: 11108154
[TBL] [Abstract][Full Text] [Related]
15. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
Miyamoto A; Murata S; Nishio A
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
[TBL] [Abstract][Full Text] [Related]
17. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
[TBL] [Abstract][Full Text] [Related]
19. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
[TBL] [Abstract][Full Text] [Related]
20. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
Li L; Vaali K; Paakkari I; Vapaatalo H
Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
